ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.25% | -57.55% | -82.79% | -217.98% | -164.97% |
| Total Depreciation and Amortization | -14.52% | -9.40% | -4.07% | 2.67% | 16.24% |
| Total Amortization of Deferred Charges | 127.41% | 329.98% | 581.35% | 1,025.00% | 949.48% |
| Total Other Non-Cash Items | 374.38% | 306.97% | 47.06% | 155.50% | -74.21% |
| Change in Net Operating Assets | 317.68% | 796.55% | 374.73% | 321.50% | 125.47% |
| Cash from Operations | 28.03% | 27.32% | 9.85% | -47.53% | -43.09% |
| Capital Expenditure | 96.38% | 97.80% | 98.40% | 56.53% | 67.89% |
| Sale of Property, Plant, and Equipment | -47.60% | 32.67% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.55% | -80.56% | -88.31% | 0.13% | 167.19% |
| Cash from Investing | -26.54% | -51.87% | -69.09% | 276.92% | 123.45% |
| Total Debt Issued | -4.70% | 85.65% | 209.19% | 29.76% | 9.66% |
| Total Debt Repaid | -131.66% | -561.26% | -2,912.43% | -- | 55.50% |
| Issuance of Common Stock | 41.18% | 12.09% | 806.00% | 532.83% | 285.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6,093.75% | 9,630.00% | 23,775.00% | -- | -- |
| Cash from Financing | -27.80% | -24.99% | 118.21% | 146.40% | 300.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.24% | 21.18% | 87.12% | 87.59% | 99.09% |